Research at Oslo University Hospital
Oslo University Hospital is a merger of three former university hospitals in Oslo. Biomedical research is one of the hospital's core activities. Research at the hospital is closely interlinked with research undertaken at the University of Oslo. More than 50% of all biomedical research in Norway is published by researchers affiliated with the hospital. Research undertaken cover both basic rsearch, translational research, and clinical research.
Oslo University Hospital has a central role in developing and supporting biomedical research within the South-Eastern Regional Health Authority. The hospital also pursues international research collaborations.
The Fridtjof Nansen prize for excellent research in science and medicine 2014 is awarded professor Kirsten Sandvig from the Department of Biochemisty at OUS and CCB at UiO for her groundbreaking work within biochemistry and cell biology.
Prizewinner Sandvig receives a medal, a diploma and 150,000 NOK at a ceremony on the 5th of May at the Norwegian Academy of Science and Letters.
Oncologists and cancer researchers from all over Norway convened at Losby gods outside Oslo on March 27-28th to participate in the first meeting held in Norway on the subject cancer genomics - entitled "Kreftgenomikk - vår nye hverdag" ("Cancer genomics - our new everyday life"). The meeting was opened by Minister of Health and Care Services Bent Høie. Talks were held by prominent cancer researchers - many of these from the Division of Cancer Medicine, Surgery and Transplantation, OUS.
The conference, which was organized by professors Ragnhild A . Lothe, Dept of Cancer Prevention Institute of Cancer Research, and Per Eystein Lønning, Haukeland University Hospital, through "Norsk kreftsatsing", has attracted attention from the Norwegian media, and several of the participants have been interviewed on national radio.
The South-Eastern Norway Regional Health Authority (Helse Sør-Øst) aims to profile ongoing excellent research in the region by calling special attention to a "Scientist of the Month".
For the month of March 2014, this honour went to Hanne Harbo, head of the "Multiple Sclerosis (MS) research group" at the Department of Neurology at the Division of Surgery and Clinical Neuroscience, Oslo University Hospital.
Epigenetics is a rapidly expanding research field that explores heritable alterations in cells and organisms not controlled by their DNA sequence. Epigenetic research is highly relevant to human health as well as agriculture and climate change.
Oslo Epigenetics Symposium 2014 held in Oslo 9.-11. April present cutting-edge epigenetic research from top international researchers. Registration is still open.
The public lecture 9th of April "Epigenetic inheritance- what is the impact ?" is by Dag E. Undlien from OUS and is free upon registration.
The institute seminar on Wednesday April 2nd will was held by the distinguished guest lecturer dr. Paul S. Meltzer, Head of the Molecular Genetics Section and Branch Chief at the Center for Cancer Research, National Cancer Institute, U.S.
Title of his talk: Bringing the New Sequencing Technologies to the Oncology Clinic: Opportunities and Challenges
The institute seminar Wednesday March 26 was held by Per Magnus Kommandantvold and Theodossis A. Theodossiou from The Research Council of Norway, and the subject of their talks was "Presentation of MSCA". This was a continuation of the recent presentation of the EUs new research programme - Horizon 2020.
Marie Sklodowska-Curie Actions (MSCA) is one of the activities in the Excellent Science-pillar of Horizon 2020, and is focused on research training and mobility.
The MSCA presentations are now available on Web TV.
Prescriptions of antibiotics in the primary health care; the role in evolution of antibiotic resistance?
Apr 2, 2014
Selected latest publications
Journ. Impact factor > 8 First or last author from Oslo University Hospital
Small nerve fiber involvement is frequent in X-linked adrenoleukodystrophy
Neurology (in press)
More selected publications